Prof. Nick Franks

  • Head Professor of Biophysics & Anaesthetics, Imperial College of London
  • Co-discoverer of neuroprotective properties of Xenon (patent filer)
  • World-renowned basic scientist widely published and recipient of international awards

Prof Mervyn Maze, MB ChB

  • Tenured professor at UCSF, with endowed chair
  • Discovered, patented, & helped market Dexmedetomidine (Precedex®), Abbott/Hospira
  • Formed AlphaRx with Nobel Laureates Brian Kobilka & Michael Levitt
  • Co-discoverer of neuroprotective properties of Xenon
  • Previous Anesthesia Appointments: UCSF – Chair, Imperial College of London – Chair/Head of Division, Stanford University – Vice-Chair
  • Widely published and recipient of eponymous lectureships, international awards – Fellowships for excellence in preclinical & translational research (including work on Xenon)

Executive Board

Bill Burns

Chief Executive Officer

  • Serial Health Care entrepreneur
  • Four new chemical entities
  • 100 new medical devices
  • $10B in revenue
  • Past President R&D and Anesthesia Laureate – Piramal Care
  • Founder/CEO – Minrad (AMEX:BUF) in 1996
  • Founder/CEO – Matrx Medical, largest manufacturer/distributor of emergency medical products in North America

Matt Napoletano

 Chief Operations Officer

  • Pharmaceutical Executive with 20 years experience
  • Strategic portfolio development & in-line commercialization of branded products
  • Commercial positions of increasing importance with Insys, Cephalon (Teva) and Berlex Labs (Schering AG / Bayer)
  • Strategic advisor to UpStart Ventures, PhotoPharmics Inc, etc

Board of Directors

Ali Arpacioglu

CEO of Adeka Ilac Aanayi A S

Bill Burns 

Neal Campbell

Chief Executive Officer at Inspiration Healthcare Group plc (LSE:IHL)

  • Engineer with post-graduate qualifications in International Trade.  
  • Started his career in Medical Devices in 1991 with Smiths Medical.
  • Hold various international sales and marketing for medical device companies. 
  • Member of the Scientific and Industry Advisory Committee of the Infant Centre, Ireland’s only perinatal research centre.

Prof. Nick Franks

Paul Harder

Prof Mervyn Maze, MB ChB

Matt Napoletano

CEO of Clinical Support Services

Govind Pindoria

Director of Venture Support at Imperial Innovations

  • Led the formation of over 35 companies and on the board of number of these companies
  • Led the sale of three Imperial spinouts to companies including Google, Evonik and Oxford University Press
  • Previous European Director of Technology for a US semiconductor equipment company
  • Previously a scientist at the Cavendish labs in Cambridge University and in Japan
  • BSc in Chemical Physics from University of Sussex, PhD in Semiconductor Physics from University of Warwick and an MBA from Imperial College Business School.

Scientific Advisory Board

World Class SAB providing expert guidance in core areas

Prof. Alex Evers


  • Physician-Scientist, Intensivist and Chair of Anesthesia at Washington University
  • Reported on the harmful effects of anesthetics in neonatal models and the protection provided by xenon

Prof. Nick Franks

Scientific Advisory Board Chairman

Prof Mervyn Maze, MB ChB

NeuroproteXeon Director

Prof. Lena Sun

Pediatric Anesthesiologist  

 Emanuel M. Papper Professor of Pediatric Anesthesiology, Columbia University

 Vice Chair, Department of Anesthesiology

 Program Director, Pediatric Fellowship Training Program

 Chief, Division of Pediatric Anesthesiology

  • Principal Investigator, Pediatric Anesthesia and Neuro-Development Assessment (PANDA) trial that addresses long-term effect of anesthesia on cognition in children
  • Member of numerous Pediatric Anesthesia Boards/Committees, and the organizer of international symposium on Pediatric Cardiovascular Medicine
  • Widely published, reviewer of multiple journals

Prof. Warren Zapol

Professor of Anaesthesia, Harvard Medical School; Reginald Jenney Professor of Anaesthesia 

 Harvard Medical School; Director, Anesthesia Center for Critical Care Research, MGH

  • Focus on the physiological and pathophysiological roles of nitric oxide (NO).
  • Pioneering studies on inhaled NO (INO) resulted in the treatment of ~30,000 patients per year in the US to vasodilate the pulmonary circulation and augment arterial oxygenation (hypoxic infants, hypoxic respiratory failure – especially after heart surgery).
  • Focus on the storage lesion of aged blood cells, and methods for preventing the toxic effects of extracellular hemoglobin that is released by hemolysis in malaria or genetic diseases such as sickle cell anemia.
  • Studying how to make the transfusion of heme-based oxygen carriers both safe and effective for transfusion in the field.
  • Widely published and recipient of international awards